TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 55 filers reported holding TALARIS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,934,853 | +84.3% | 1,561,092 | 0.0% | 0.05% | +74.2% |
| Q4 2022 | $1,592,314 | -61.2% | 1,561,092 | 0.0% | 0.03% | -61.7% |
| Q3 2022 | $4,106,000 | -41.7% | 1,561,092 | 0.0% | 0.08% | -46.4% |
| Q2 2022 | $7,041,000 | -54.2% | 1,561,092 | 0.0% | 0.15% | -37.3% |
| Q1 2022 | $15,361,000 | -35.6% | 1,561,092 | 0.0% | 0.24% | -21.0% |
| Q4 2021 | $23,869,000 | +15.4% | 1,561,092 | 0.0% | 0.30% | +11.7% |
| Q3 2021 | $20,686,000 | -7.7% | 1,561,092 | 0.0% | 0.27% | -9.3% |
| Q2 2021 | $22,411,000 | – | 1,561,092 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 682,923 | $9,260,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 814,163 | $11,040,000 | 0.92% |
| Cormorant Asset Management, LP | 1,215,847 | $16,349,000 | 0.66% |
| Artal Group S.A. | 2,064,262 | $27,991,000 | 0.63% |
| Logos Global Management LP | 507,923 | $6,887,000 | 0.50% |
| Eventide Asset Management | 1,561,092 | $20,686,000 | 0.27% |
| Blackstone Inc. | 8,089,315 | $109,691,000 | 0.24% |
| Avidity Partners Management LP | 455,000 | $6,170,000 | 0.14% |
| HHLR ADVISORS, LTD. | 761,885 | $10,331,000 | 0.14% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $44,607,000 | 0.12% |